NT5E and leukemia: Exploring the role of CD73 in leukemia is just the beginning; subsequent research should focus on designing small molecule inhibitors or monoclonal antibodies that target CD73 expression at specific sites, which is informed by its role in the immune evasion of leukemia and drug resistance mechanisms.